Logo image of LBI.CA

LIONS BAY CAPITAL INC (LBI.CA) Stock Fundamental Analysis

TSX-V:LBI - TSX Venture Exchange - CA5362631064 - Common Stock - Currency: CAD

0.025  +0.01 (+25%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LBI. LBI was compared to 0 industry peers in the Unkown industry. LBI has a bad profitability rating. Also its financial health evaluation is rather negative. LBI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LBI had negative earnings in the past year.
LBI had a negative operating cash flow in the past year.
LBI had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LBI reported negative operating cash flow in multiple years.
LBI.CA Yearly Net Income VS EBIT VS OCF VS FCFLBI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

Industry RankSector Rank
ROA -42.85%
ROE -67.71%
ROIC N/A
ROA(3y)-40.42%
ROA(5y)-16.88%
ROE(3y)-53.88%
ROE(5y)-24.67%
ROIC(3y)N/A
ROIC(5y)N/A
LBI.CA Yearly ROA, ROE, ROICLBI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

LBI's Profit Margin has declined in the last couple of years.
LBI's Operating Margin has declined in the last couple of years.
LBI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y14.19%
OM growth 5Y-2.98%
PM growth 3Y22.58%
PM growth 5Y-1.52%
GM growth 3YN/A
GM growth 5YN/A
LBI.CA Yearly Profit, Operating, Gross MarginsLBI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

More info and screens

2

2. Health

2.1 Basic Checks

LBI has about the same amout of shares outstanding than it did 1 year ago.
LBI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LBI has an improved debt to assets ratio.
LBI.CA Yearly Shares OutstandingLBI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
LBI.CA Yearly Total Debt VS Total AssetsLBI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -1.78, we must say that LBI is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.16 indicates that LBI is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -1.78
ROIC/WACCN/A
WACCN/A
LBI.CA Yearly LT Debt VS Equity VS FCFLBI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

LBI has a Current Ratio of 1.42. This is a normal value and indicates that LBI is financially healthy and should not expect problems in meeting its short term obligations.
LBI has a Quick Ratio of 1.42. This is a normal value and indicates that LBI is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
LBI.CA Yearly Current Assets VS Current LiabilitesLBI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

LBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.94%, which is quite impressive.
LBI shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.19%.
EPS 1Y (TTM)27.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.55%
Revenue 1Y (TTM)45.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%94.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LBI.CA Yearly Revenue VS EstimatesLBI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M
LBI.CA Yearly EPS VS EstimatesLBI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LBI.CA Price Earnings VS Forward Price EarningsLBI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LBI.CA Per share dataLBI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIONS BAY CAPITAL INC

TSX-V:LBI (3/4/2025, 7:00:00 PM)

0.025

+0.01 (+25%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap3.55M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS-0.01
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.85%
ROE -67.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.42%
ROA(5y)-16.88%
ROE(3y)-53.88%
ROE(5y)-24.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y14.19%
OM growth 5Y-2.98%
PM growth 3Y22.58%
PM growth 5Y-1.52%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover-0.26
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z -1.78
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%94.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-185.01%
FCF growth 3YN/A
FCF growth 5Y-9.31%
OCF growth 1Y-196.08%
OCF growth 3YN/A
OCF growth 5Y-9.31%